2025-03-27
32 分钟Hello, and welcome to Clinical Trial Blazers, a podcast by Paracel Biotech,
where we explore the human stories behind breakthrough clinical research.
In this series, we'll dive deep into the world of clinical development,
connecting you with leading voices across biopharma and biotech,
to hear about the decisions, risks and accomplishments that define these trial blazers' legacies.
Together, we'll explore the pivotal choices,
bold risks and remarkable achievements that define these trial blazers' legacies,
uncovering the heart, grit and ingenuity driving the future of scientific innovation.
I am Alberto Grignolo, your host on this journey.
Whether you're an emerging leader in biotech, or someone curious about the future of clinical trials,
this series is here to inform and inspire you.
In this episode, we'll hear from Michael Bailey,
president and CEO of Aveo Oncology, a company dedicated to advancing targeted cancer therapies.
Michael, it's a pleasure to have you joining me today and very much looking forward to our conversation.
Thank you, Alberto.
Would you begin by introducing yourself and telling me a little bit about your background in biotech?
Sure.
Well, thanks, Alberto, and I appreciate you all having me on the show today.
I'm Michael Bailey.
I'm the president and CEO of Aveo Oncology, which is an LG Chem company.